$831 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 106 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 23.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Sell | AMICUS THERAPEUTICS | $46,167,000 | -4.3% | 3,394,623 | -32.6% | 5.55% | -15.3% |
| AERI | Sell | AERIE PHARMACEUTIC | $39,898,000 | -2.5% | 839,954 | -25.9% | 4.80% | -13.8% |
| ALNY | Sell | ALNYLAM PHARMACUETCL | $36,543,000 | +1.2% | 391,041 | -21.1% | 4.40% | -10.5% |
| APLS | Sell | APELLIS PHARMACEUTIC | $33,693,000 | +17.8% | 1,727,829 | -20.3% | 4.05% | +4.3% |
| TDOC | Sell | TELADOC HEALTH | $32,886,000 | +5.0% | 591,481 | -6.4% | 3.96% | -7.1% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $22,185,000 | -28.1% | 909,968 | -58.0% | 2.67% | -36.4% |
| PTLA | Sell | PORTOLA PHARMACEUTIC | $21,145,000 | +31.5% | 609,357 | -26.0% | 2.54% | +16.4% |
| NVS | Sell | NOVARTIS AGsp adr | $19,617,000 | +7.1% | 204,046 | -4.4% | 2.36% | -5.2% |
| PFE | Sell | PFIZER INC | $17,800,000 | -4.1% | 419,126 | -1.5% | 2.14% | -15.2% |
| CELG | Sell | CELGENE CORP | $16,953,000 | -33.4% | 179,700 | -54.7% | 2.04% | -41.1% |
| HRC | Sell | HILL-ROM HLDS INC | $16,810,000 | +18.5% | 158,799 | -0.9% | 2.02% | +4.9% |
| WMGI | Sell | WRIGHT MED GROUP N V | $15,765,000 | +8.4% | 501,272 | -6.2% | 1.90% | -4.1% |
| RARX | Sell | RA PHARMACEUTICALS | $15,378,000 | +5.7% | 686,513 | -14.1% | 1.85% | -6.5% |
| GBT | Sell | GLOBAL BLOOD THERA | $14,468,000 | +24.7% | 273,341 | -3.3% | 1.74% | +10.3% |
| COLL | Sell | COLLEGIUM PHARMACEUT | $14,146,000 | -28.8% | 934,334 | -19.2% | 1.70% | -37.0% |
| BMY | Sell | BRISTOL MYERS SQUIBB | $10,434,000 | -22.0% | 218,697 | -15.0% | 1.26% | -30.9% |
| MDT | Sell | MEDTRONIC PLC | $9,468,000 | -11.4% | 103,951 | -11.5% | 1.14% | -21.6% |
| PODD | Sell | INSULET CORP | $8,640,000 | +13.0% | 90,860 | -5.7% | 1.04% | 0.0% |
| TNDM | Sell | TANDEM DIABETES CARE | $8,615,000 | +11.7% | 135,667 | -33.2% | 1.04% | -1.1% |
| UNH | Sell | UNITEDHEALTH GRP INC | $8,528,000 | -21.9% | 34,488 | -21.3% | 1.03% | -30.8% |
| VRAY | Sell | VIEWRAY INC | $8,301,000 | +13.9% | 1,123,264 | -6.4% | 1.00% | +0.7% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $7,135,000 | -8.5% | 80,321 | -12.3% | 0.86% | -19.1% |
| CI | Sell | CIGNA CORP | $6,563,000 | -48.5% | 40,809 | -39.2% | 0.79% | -54.5% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $6,192,000 | -8.5% | 82,600 | -15.2% | 0.74% | -19.0% |
| Sell | INTEC PHARMA LTD JER | $5,930,000 | -28.9% | 809,000 | -26.9% | 0.71% | -37.1% | |
| ADMS | Sell | ADAMAS PHARMACEUTI | $5,751,000 | -40.6% | 808,924 | -28.7% | 0.69% | -47.4% |
| MGTX | Sell | MEIRAGTX HLDINGS PLC | $5,529,000 | +40.6% | 320,896 | -21.3% | 0.66% | +24.5% |
| SAGE | Sell | SAGE THERAPEUTICS | $5,026,000 | +41.4% | 31,600 | -14.8% | 0.60% | +25.3% |
| WCG | Sell | WELLCARE HEALTH PLAN | $4,384,000 | -4.4% | 16,251 | -16.3% | 0.53% | -15.4% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $3,729,000 | -37.9% | 20,271 | -44.0% | 0.45% | -45.0% |
| EXAS | Sell | EXACT SCIENCES CORP | $3,326,000 | -60.7% | 38,400 | -71.4% | 0.40% | -65.2% |
| BGNE | Sell | BEIGENE LIMITEDsp adr | $1,442,000 | -31.1% | 10,927 | -26.8% | 0.17% | -39.3% |
| UHS | Sell | UNIVERSAL HEALTH SVCcl b | $385,000 | +13.9% | 2,881 | -0.5% | 0.05% | 0.0% |
| SRRA | Sell | SIERRA ONCOLOGY INC | $240,000 | -30.0% | 140,376 | -30.4% | 0.03% | -38.3% |
| IMGN | Sell | IMMUNOGEN INC | $157,000 | -75.8% | 58,013 | -57.1% | 0.02% | -78.4% |
| BLRX | Sell | BIOLINERX LTDsp adr | $77,000 | -11.5% | 178,297 | -10.1% | 0.01% | -25.0% |
| PLX | Exit | PROTALIX BIOTHERA | $0 | – | -99,667 | -100.0% | -0.00% | – |
| KANG | Exit | IKANG HEALTHCARE Gsp adr | $0 | – | -11,513 | -100.0% | -0.03% | – |
| CHRS | Exit | COHERUS BIOSCIENCES | $0 | – | -27,987 | -100.0% | -0.03% | – |
| CERS | Exit | CERUS CORP | $0 | – | -60,576 | -100.0% | -0.04% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -2,066 | -100.0% | -0.04% | – |
| RARE | Exit | ULTRAGENYX PHARMAC | $0 | – | -9,047 | -100.0% | -0.05% | – |
| ALDR | Exit | ALDER BIOPHARMACEU | $0 | – | -128,300 | -100.0% | -0.18% | – |
| CSII | Exit | CARDIOVASCULAR SYS | $0 | – | -100,862 | -100.0% | -0.39% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -18,301 | -100.0% | -0.75% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -112,029 | -100.0% | -0.86% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -1,301,305 | -100.0% | -2.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.